Forte Biosciences (FBRX) Other Non-Current Assets (2016 - 2026)

Forte Biosciences (FBRX) has 11 years of Other Non-Current Assets data on file, last reported at $2.0 million in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $2.0 million, up 7912.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 million (up 7912.0% YoY), and the FY2025 annual result was $2.1 million, up 1393.48% from the prior year.
• Other Non-Current Assets eased to $2.0 million in Q1 2026 per FBRX's latest filing, from $2.1 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $2.1 million in Q4 2025 and troughed at $12000.0 in Q1 2023.
• A 5-year average of $374823.5 and a median of $56000.0 in 2024 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2023 and 2026: Other Non-Current Assets slumped 98.66% in 2023, then soared 7912.0% in 2026.
• A 5-year view of Other Non-Current Assets shows it stood at $486000.0 in 2022, then slumped by 89.09% to $53000.0 in 2023, then jumped by 160.38% to $138000.0 in 2024, then surged by 1393.48% to $2.1 million in 2025, then dropped by 2.81% to $2.0 million in 2026.
• Business Quant data shows FBRX's Other Non-Current Assets at $2.0 million in Q1 2026, $2.1 million in Q4 2025, and $25000.0 in Q3 2025.